Sarepta Therapeutics, Inc.

UNITED CAPITAL FINANCIAL ADVISORS, LLC SRPT

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/15/2026

Shares

11,895

Value ($000)

259

Weight

0.0%

2019 Q3 - 2026 Q1 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/15/2026	259	0.0%	11,895	3/31/2026
2021 Q1	5/14/2021	962	0.0%	12,905	3/31/2021
2020 Q4	2/17/2021	2,220	0.0%	13,020	12/31/2020
2020 Q3	11/13/2020	1,714	0.0%	12,131	9/30/2020
2020 Q2	8/13/2020	2,093	0.0%	13,051	6/30/2020
2020 Q1	8/11/2020	1,478	0.0%	15,114	3/31/2020
2019 Q3	2/14/2020	1,147	0.0%	15,223	9/30/2019